Trademark Overview
On Tuesday, November 11, 2025, a trademark application was filed for MEDICINES360 ASPIRE with the United States Patent and Trademark Office. The USPTO has given the MEDICINES360 ASPIRE trademark a serial number of 99491156. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 11, 2025. This trademark is owned by Medicines360. The MEDICINES360 ASPIRE trademark is filed in the Chemical Products, Pharmaceutical Products, Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing medical information in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; Medical diagnostic testing, monitoring and reporting services; providing medical information in the field of medical testing, risk prediction and classification of maternal health conditions and health conditions during pregnancy and labor
Reagents and assays for scientific and research use
Providing medical and scientific research information in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; Providing online non-downloadable software for medical diagnostic testing or treatment; Software as a service (SAAS) services featuring software for medical assessment, diagnostic testing or treatment; Providing online non-downloadable software, for medical testing, reports for risk prediction and classification and information in the field of maternal health and health conditions during pregnancy and labor
Medical reagents and assays; Medical diagnostic reagents and assays; reagents and assays for use in treating, monitoring, testing, analyzing and detecting medical conditions, diseases and disorders in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; diagnostic biomarker reagents and assays for medical purposes
Promoting awareness of and organizing and developing projects to support women’s health
Educational services, including conducting classes, seminars, conferences, workshops, and online webinars for physicians and other medical service providers to provide instruction on the use of software and medical reagents and assays, and distribution of training materials in connection therewith